Julian Segura received his MD degree from the University of Alcalá (Madrid) and completed his residency and fellowship in nephrology at the Hospital “12 de Octubre” in Madrid, Spain. He started working at the Hypertension Unit at the same hospital in 1998, and has been head of the unit there since 2013.His principal areas of interest are hypertension, the kidney, and cardiovascular risk factors. He has published several papers on the development and prevalence of renal damage in hypertensive patients, the relationship between hypertensive renal damage and cardiovascular risk, and the relevance of metabolic syndrome in hypertensive patients.He is a member of the Spanish Ambulatory Blood Pressure Monitoring Registry’s Scientific Committee, the European Society of Hypertension (ESH), the Spanish Society of Nephrology and the International Society of Nephrology, and in March 2015 he was elected president of the Spanish Society of Hypertension. In 2001, he received the diploma of Clinical Hypertension Specialist supported by the ESH. From 2005 to 2014, he was the executive editor of the journal of the Spanish Society of Hypertension, and from 2008 to 2011, he was a member of the editorial board of the Journal of Hypertension. He acts as referee for several journals, including the Journal of Hypertension, Journal of Human Hypertension, and the Spanish Journal of Hypertension.

• Clinical case 1: Adult Patient with white-coat hypertension.- Clinical case 2: Adult Patient with masked hypertension.- Clinical case 3: Adult Patient with isolated nocturnal hypertension.- Clinical case 4: Adult Patient with isolated diurnal hypertension.- Clinical case 5: Adult Patient with hypertension and OSAS.- Clinical case 6: Adult Patient with pseudo-resistant hypertension.- Clinical case 7: Adult Patient with resistant hypertension.- Clinical case 8: Adult Patient with drug-induced hypotension.

Julian Segura received his MD degree from the University of Alcalá (Madrid) and completed his residency and fellowship in nephrology at the Hospital “12 de Octubre” in Madrid, Spain. He started working at the Hypertension Unit at the same hospital in 1998, and has been head of the unit there since 2013.His principal areas of interest are hypertension, the kidney, and cardiovascular risk factors. He has published several papers on the development and prevalence of renal damage in hypertensive patients, the relationship between hypertensive renal damage and cardiovascular risk, and the relevance of metabolic syndrome in hypertensive patients.He is a member of the Spanish Ambulatory Blood Pressure Monitoring Registry’s Scientific Committee, the European Society of Hypertension (ESH), the Spanish Society of Nephrology and the International Society of Nephrology, and in March 2015 he was elected president of the Spanish Society of Hypertension. In 2001, he received the diploma of Clinical Hypertension Specialist supported by the ESH. From 2005 to 2014, he was the executive editor of the journal of the Spanish Society of Hypertension, and from 2008 to 2011, he was a member of the editorial board of the Journal of Hypertension. He acts as referee for several journals, including the Journal of Hypertension, Journal of Human Hypertension, and the Spanish Journal of Hypertension.

• Clinical case 1: Adult Patient with white-coat hypertension.- Clinical case 2: Adult Patient with masked hypertension.- Clinical case 3: Adult Patient with isolated nocturnal hypertension.- Clinical case 4: Adult Patient with isolated diurnal hypertension.- Clinical case 5: Adult Patient with hypertension and OSAS.- Clinical case 6: Adult Patient with pseudo-resistant hypertension.- Clinical case 7: Adult Patient with resistant hypertension.- Clinical case 8: Adult Patient with drug-induced hypotension.

Julian Segura received his MD degree from the University of Alcalá (Madrid) and completed his residency and fellowship in nephrology at the Hospital “12 de Octubre” in Madrid, Spain. He started working at the Hypertension Unit at the same hospital in 1998, and has been head of the unit there since 2013.His principal areas of interest are hypertension, the kidney, and cardiovascular risk factors. He has published several papers on the development and prevalence of renal damage in hypertensive patients, the relationship between hypertensive renal damage and cardiovascular risk, and the relevance of metabolic syndrome in hypertensive patients.He is a member of the Spanish Ambulatory Blood Pressure Monitoring Registry’s Scientific Committee, the European Society of Hypertension (ESH), the Spanish Society of Nephrology and the International Society of Nephrology, and in March 2015 he was elected president of the Spanish Society of Hypertension. In 2001, he received the diploma of Clinical Hypertension Specialist supported by the ESH. From 2005 to 2014, he was the executive editor of the journal of the Spanish Society of Hypertension, and from 2008 to 2011, he was a member of the editorial board of the Journal of Hypertension. He acts as referee for several journals, including the Journal of Hypertension, Journal of Human Hypertension, and the Spanish Journal of Hypertension.

• Clinical case 1: Adult Patient with white-coat hypertension.- Clinical case 2: Adult Patient with masked hypertension.- Clinical case 3: Adult Patient with isolated nocturnal hypertension.- Clinical case 4: Adult Patient with isolated diurnal hypertension.- Clinical case 5: Adult Patient with hypertension and OSAS.- Clinical case 6: Adult Patient with pseudo-resistant hypertension.- Clinical case 7: Adult Patient with resistant hypertension.- Clinical case 8: Adult Patient with drug-induced hypotension.